Lanean...
Hemostatic agents of broad applicability produced by selective tuning of factor Xa zymogenicity
There is a clinical need to develop safe therapeutic strategies to mitigate bleeding. Previously, we found that a novel zymogen-like factor Xa variant (FXa-I16L) was effective in correcting the coagulation defect in hemophilic mice. Here we expand the mutational framework to tune the FX(a) zymogen-l...
Gorde:
| Argitaratua izan da: | Blood |
|---|---|
| Egile Nagusiak: | , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
American Society of Hematology
2015
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4492200/ https://ncbi.nlm.nih.gov/pubmed/25896653 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2015-03-634329 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|